A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Clinical trial NCT04179864 · TERMINATED

Trial details

NCT number: NCT04179864
Sponsor: Epizyme, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2019-11-18
Primary completion: 2024-11-04
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.